NCT00156208View on ClinicalTrials.gov

Safety of Treatment of Uterine Fibroids With Asoprisnil

PHASE3CompletedINTERVENTIONAL

Enrollment

166

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions

Fibroid UterusLeiomyomaMenorrhagiaMetrorrhagiaUterine Fibroids

Interventions

DRUG

Asoprisnil

10mg Tablet, oral Daily for 18 months

DRUG

Asoprisnil

25 mg Tablet, oral Daily for 18 months

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Abbott

INDUSTRY